Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2012
03/27/2012CA2473669C Use and preparation of dosage forms containing benzimidazole derivatives and a buffer
03/27/2012CA2464759C Apparatus and method for manufacturing encapsulated products
03/27/2012CA2454699C Method for treating primary insomnia
03/27/2012CA2407423C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
03/27/2012CA2406179C Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
03/27/2012CA2389570C Methods for treating mild cognitive impairment
03/27/2012CA2378497C Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
03/27/2012CA2371922C Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
03/22/2012WO2012037534A1 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral ph
03/22/2012WO2012037530A1 Stabilization of immunoglobulins and other proteins through aqueous formulations with sodium chloride at weak acidic to neutral ph
03/22/2012WO2012037380A2 Formulations of guanylate cyclase c agonists and methods of use
03/22/2012WO2012037117A1 Aqueous drug delivery system comprising off - flavor masking agent
03/22/2012WO2012036983A2 Removal of toxins from gastrointestinal fluids
03/22/2012WO2012036746A1 Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
03/22/2012WO2012036697A1 Micro devices biomedical applications and uses of the same
03/22/2012WO2012036589A1 Hydrogel composition for the treatment of burns
03/22/2012WO2012036585A1 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
03/22/2012WO2012036442A2 Adhesive composition comprising tannin, polyethylene glycol, and water, lower alcohol or mixture thereof
03/22/2012WO2012036430A2 Non-aqueous oily injectable formulation exhibiting preservative efficacy
03/22/2012WO2012036078A1 Drug-containing film-coated particles in which unpleasant taste is masked
03/22/2012WO2012035794A1 Octreotide-modified nano preparation for treatment of cancer or palliative care of cancer
03/22/2012WO2012035559A2 Sustained release pharmaceutical compositions comprising pregabalin
03/22/2012WO2012035409A1 Sustained release compositions of anti-alzheimer's agents
03/22/2012WO2012035381A1 A novel dermaceutical cream made using sodium fusidate and betamethasone valerate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035380A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035379A1 A novel dermaceutical cream made using sodium fusidate, miconazole nitrate and fluticasone propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035378A1 A dermaceutical cream made using sodium fusidate, and fluticasone propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035377A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it
03/22/2012WO2012035375A1 A novel dermaceutical cream made using sodium fusidate and mometasone furoate, a process to make the same, and a method of treatment using it
03/22/2012WO2012035283A1 Pharmaceutical composition
03/22/2012WO2012035074A1 Super-saturating delivery vehicles for poorly water-soluble pharmaceutical and cosmetic active ingredients
03/22/2012WO2012034871A2 Method for producing active ingredient beads
03/22/2012WO2012034704A1 Treatment of vascular diseases using encapsulated cells encoding and secreting glp-1, or a fragment or variant thereof
03/22/2012WO2012034659A2 Pharmaceutical composition containing an electrochemically activated salt solution
03/22/2012WO2012034540A1 Anti-tumor pharmaceutical composition
03/22/2012WO2012034498A1 Product of functional health food that enhances organ immunity
03/22/2012WO2012034379A1 Method for preparing ph sensitive metal organic coordination polymer
03/22/2012WO2012034360A1 Insulin crystal microsphere, suspension and preparation method thereof
03/22/2012WO2012016109A3 Compounds and methods for skin repair
03/22/2012WO2012013994A3 Ph-dependent gradual release pharmaceutical composition
03/22/2012WO2012009723A8 C-met modulator pharmaceutical compositions
03/22/2012WO2012001074A3 Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
03/22/2012WO2011163069A3 Protease triggered release of molecules from hydrogels
03/22/2012WO2011149814A3 Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
03/22/2012WO2011141929A3 Aqueous pharmaceutical compositions of fluticasone and olopatadine
03/22/2012WO2011140024A3 Nanoparticles produced from recombinant polymers and methods of making and using the same
03/22/2012WO2011139101A3 Method for producing the solid phase of a water-insoluble gel composition and a water-insoluble gel produced thereby
03/22/2012WO2011133925A3 Targeted and light-activated cytosolic drug delivery
03/22/2012WO2011132114A3 Tuberculosis drug based on 4-thioureido-iminomethylpyridinium perchlorate: method of preparation and treatment
03/22/2012WO2011116286A3 Stable bortezomib formulations
03/22/2012WO2011097149A3 Taxane-and taxoid-protein compositions
03/22/2012WO2011095812A3 Composition comprising mixed metal compounds and xanthan
03/22/2012WO2011089604A3 Material and method for treating internal cavities
03/22/2012WO2011085158A3 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
03/22/2012WO2011019718A3 Personal care composition with improved spreadability
03/22/2012WO2011003603A3 Composition for the production of tablets, and method for the production of said composition
03/22/2012WO2004050019A9 Method and compositions for treating anxiety
03/22/2012WO1996002235A9 Injectable res avoiding inorganic particles
03/22/2012US20120071967 One-step phosphorylcholine-linked polymer coating and drug loading of stent
03/22/2012US20120071865 Flowable hydrogels for control of cell in-migration
03/22/2012US20120071839 Tampon
03/22/2012US20120071538 Pharmaceutical formulatons
03/22/2012US20120071537 New Oral Formulation
03/22/2012US20120071488 Melting tablet containing a sildenafil salt
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120070505 Functional amphipilic molecule or macromolecule formulations with multiple compartments
03/22/2012US20120070504 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same
03/22/2012US20120070503 Nanoparticle-Based Targeted Drug Delivery For In Vivo Bone Loss Mitigation
03/22/2012US20120070502 Methods of treating cancer
03/22/2012US20120070501 Method and Formulation for Treating Resistance to Antihypertensives and Related Conditions
03/22/2012US20120070500 Nanoparticles Of Cerium Oxide Targeted To An Amyloid-Beta Antigen Of Alzheimer's Disease And Associated Methods
03/22/2012US20120070499 Delayed-release glucocorticoid treatment of rheumatoid disease
03/22/2012US20120070498 Submicron Particles of Antineoplastic Agents
03/22/2012US20120070497 Use of boswellic acids for the prophylaxis and/or treatment of damage to and/or inflammation of the islets of langerhans
03/22/2012US20120070496 Antidepressant dosage form
03/22/2012US20120070495 Oral formulations and lipophilic salts of methylnaltrexone
03/22/2012US20120070494 Treatment for Attention-Deficit Hyperactivity Disorder
03/22/2012US20120070493 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/22/2012US20120070492 Rhein or diacerein compositions
03/22/2012US20120070491 Casb7439 constructs
03/22/2012US20120070490 Anti-trypanosomal peptides and uses thereof
03/22/2012US20120070489 Combination therapy for treatment of fiv infection
03/22/2012US20120070488 Method of inducing neutralizing antibodies to human immunodeficiency virus
03/22/2012US20120070487 Alkylsaccharide compositions with nutraceuticals
03/22/2012US20120070486 Methods and compositions related to prefoldin and its regulation
03/22/2012US20120070485 method for producing a device applicable to biological tissues, particularly a patch for treating damaged tissues, and a device obtained by said method
03/22/2012US20120070483 Multi-Functional Biocompatible Coatings for Intravascular Devices
03/22/2012US20120070480 Antimicrobial disposable absorbent articles
03/22/2012US20120070477 Dry powder fibrin sealant
03/22/2012US20120070476 Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
03/22/2012US20120070475 Zero Calorie Polyphenol Aqueous Dispersions
03/22/2012US20120070474 Polymer compound for biomedical use and biochip substrate using such a polymer compound
03/22/2012US20120070473 Apparatus and Method for Reducing the Occurrence of Post-Surgical Adhesions
03/22/2012US20120070472 Chronotherapeutic compositions and methods of their use
03/22/2012US20120070471 Administration of enoxoparin sodium to patients 75 years and older with st-segment elevation myocardial infarction
03/22/2012US20120070470 Hemostatic compositions, devices, and methods
03/22/2012US20120070469 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents
03/22/2012US20120070468 Removal of toxins from gastrointestinal fluids
03/22/2012US20120070467 Ophthalmic Drug Delivery
03/22/2012US20120070466 Conjugated Polymeric Material and Uses Thereof
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 2991